96
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain

, , , &
Pages 7-13 | Published online: 20 Jan 2012

References

  • BouhassiraDLantéri-MinetMAttalNLaurentBTouboulCPrevalence of chronic pain with neuropathic characteristics in the general populationPain200813638038717888574
  • Mallis GagnonAFurlanALakhaSFYegneswaranBSystematic review of the prevalence of neuropathic painEur J Pain200711Suppl 1S202S203 [Abstract No. 457]
  • TorranceNSmithBHBennettMILeeAJThe epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population surveyJ Pain2006728128916618472
  • O’ConnorABDworkinRHTreatment of neuropathic pain: an overview of recent guidelinesAm J Med200912210 SupplS22S32
  • NotoCPappagalloMSzallasiANGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic painCurr Opin Investig Drugs200910702710
  • DworkinRHO’ConnorABBackonjaMPharmacologic management of neuropathic pain: evidence-based recommendationsPain200713223725117920770
  • StillmanMClinical approach to patients with neuropathic painCleve Clin J Med20067372673916913197
  • CaterinaMJSchumacherMATominagaMThe capsaicin receptor: a heat-activated ion channel in the pain pathwayNature19973898168249349813
  • SzallasiAAutoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including manActa Physiol Scand1995155Suppl 6291688553871
  • SzallasiABlumbergPMVanilloid (capsaicin) receptors and mechanismsPharmacol Rev19995115921110353985
  • KennedyWRVanhoveGFLuSPA randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteersJ Pain20101157958720400377
  • MalmbergABMizisinAPCalcuttNAReduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patchPain200411136036715363880
  • AnandPBleyKTopical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patchBr J Anaesth201110749050221852280
  • McCormackPLCapsaicin dermal patch: in non-diabetic peripheral neuropathic painDrugs2010701831184220836576
  • BackonjaMWallaceMSBlonskyERNGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind studyLancet Neurol200871106111218977178
  • SimpsonDMEstanislaoLBrownSJSampsonJAn open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathyJ Pain Symptom Manage20083529930617959343
  • SimpsonDMBrownSTobiasJControlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathyNeurology2008702305231318541884
  • IrvingGABackonjaMDuntemanEA multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgiaPain Med2011129910921087403
  • BackonjaMMalanTPVanhoveGFTobiasJKfor the C102/106 Study GroupNGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extensionPain Med20101160060820113411
  • WebsterLRMalanTPTuchmanMMMollenMDTobiasJKVanhoveGFA multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgiaJ Pain20101197298220655809
  • FarrarJTYoungJPJrLaMoreauxLWerthJLPooleRMClinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain20019414915811690728
  • US Food and Drug Administration Center for Drug Evaluation and ResearchGuidance for industry: skin irritation and sensitization testing of generic transdermal drug productsWashington, DCUS Department of Health and Human Services Available from: http://www.fda.gov/ohrms/dockets/98fr/990236Gd.pdf#search=%22HillTop%20Research%2C%20Inc.%20dermal%20irritation%22Accessed February 22, 2010
  • SchneiderLSClarkCMDoodyRADCS Prevention Instrument Project: ADCS-clinicians’ global impression of change scales (ADCSCGIC), self-rated and study partner-rated versionsAlzheimer Dis Assoc Disord2006204 Suppl 3S124S13817135806
  • BabbarSMarierJFMouksassiMSPharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic painTher Drug Monit20093150251019494795